In summary, our findings revealed a prooncogenic role of PRDX2 in the progression of NSCLC, downregulation of PRDX2 significantly inhibited the proliferation, migration, and invasion of NSCLC cells, as well as promoted apoptosis. This evidence concerns the gene PRDX2 and non-small cell lung carcinoma.